mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
AZD0530 |
FIMM |
pan-cancer |
AAC |
0.15 |
0.4 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
AP-24534 |
FIMM |
pan-cancer |
AAC |
-0.16 |
0.4 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.4 |